Name: Survodutide
Brand: Lilipeptide
SKU: LILI-survodutide
Price: 420.00 USD
Availability: InStock

What is Survodutide?

Survodutide (BI 456906) is a synthetic peptide developed to combine two receptor activities in one molecule, pairing GLP-1’s established appetite and glucose effects with glucagon-receptor agonism aimed at increasing energy expenditure. It is structurally and mechanistically distinct from triple agonists such as retatrutide, which add a third, GIP-receptor component.

This listing is Survodutide from Lilipeptide (China), sold on Stairway to Gray with escrow: your payment is held until the order arrives and only then released to the brand.

How it is understood to work

GLP-1 receptor activation is studied for reducing appetite and improving glucose-dependent insulin secretion, while glucagon receptor activation is examined for its role in increasing hepatic fatty-acid oxidation and overall energy expenditure, an approach researchers use to target both body weight and liver fat through separate pathways within one molecule.

Research status

Survodutide has advanced through Phase 2 human clinical trials in obesity and metabolic dysfunction-associated steatohepatitis (MASH), with published data describing reductions in body weight and liver fat relative to placebo; it remains an investigational compound without regulatory approval, and Phase 3 and long-term safety data are still being generated.

This listing: Lilipeptide Survodutide

Brand: Lilipeptide
Also sold by: Uther Peptide 10mg $230.00 · HK Peptide 10mg $300.00 · TFC Peptides 10mg $210.00 · Jinlu Peptides 10mg $270.00

Lab testing

There is no public lab report for this listing yet. We can ask the brand for the batch COA before you order. Many buyers also split an independent HPLC test with others who bought the same batch.

Request the batch COA · How group testing works

Bought through escrow: the brand is only paid after you confirm delivery. If the parcel never arrives, or an independent test shows the wrong compound or a significant under-fill, open a claim before releasing payment.

Specifications

Compound: Survodutide
Also known as: BI 456906
Class: Investigational dual glucagon/GLP-1 receptor agonist
Form: Lyophilized (freeze-dried) powder
Brand: Lilipeptide · China

Handling & storage

Supplied as a lyophilized powder; store unopened vials at -20C protected from light, and once reconstituted with bacteriostatic water keep refrigerated at 2-8C for use within the study’s defined timeframe.

Questions

Is survodutide a GIP receptor agonist?

No. Survodutide targets the glucagon and GLP-1 receptors specifically; it does not act on the GIP receptor, which distinguishes it from GIP/GLP-1 dual agonists and from triple agonists like retatrutide.

Has survodutide been approved for clinical use?

No. It is still in clinical trials, most notably Phase 2 studies in obesity and MASH, and has not received marketing approval from any regulatory body.

For laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.